🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

AtriCure Inc (ATRC)

NASDAQ
Currency in USD
37.45
+0.09(+0.24%)
Closed
After Hours
37.450.00(0.00%)
ATRC Scorecard
Full Analysis
4 analysts have revised their earnings downwards for the upcoming period
Fair Value
Day's Range
37.0738.27
52 wk Range
18.9443.00
Prev. Close
37.36
Open
37.32
Day's Range
37.07-38.27
52 wk Range
18.94-43
Volume
366,505
Average Volume (3m)
596,779
1-Year Change
6.79%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
ATRC Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
44.22
Upside
+18.08%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory
Show more

AtriCure Inc Company Profile

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula’s to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Compare ATRC to Peers and Sector

Metrics to compare
ATRC
Peers
Sector
Relationship
P/E Ratio
−46.9x−1.8x−0.7x
PEG Ratio
0.85−0.020.00
Price/Book
3.9x4.0x2.6x
Price / LTM Sales
4.1x2.8x3.2x
Upside (Analyst Target)
6.8%47.7%43.9%
Fair Value Upside
Unlock2.9%6.5%Unlock

People Also Watch

36.08
HRMY
+3.35%
50.14
OMCL
-4.42%
45.73
EXLS
+0.53%
99.07
PRCT
+2.95%

FAQ

What Is the AtriCure (ATRC) Stock Price Today?

The AtriCure stock price today is 37.45

What Stock Exchange Does AtriCure Trade On?

AtriCure is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for AtriCure?

The stock symbol for AtriCure is "ATRC."

What Is the AtriCure Market Cap?

As of today, AtriCure market cap is 1.83B.

What is AtriCure Earnings Per Share?

The AtriCure EPS is -0.832.

What Is the Next AtriCure Earnings Date?

AtriCure will release its next earnings report on Feb 25, 2025.

From a Technical Analysis Perspective, Is ATRC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.